Literature DB >> 15897818

Triple total cervical vertebrectomy for a giant cell tumor: case report.

Olivier Gille1, Christian Soderlund, Jérome Berge, Oumar Sacko, Jean-Marie Vital.   

Abstract

STUDY
DESIGN: Case report of a triple total cervical vertebrectomy.
OBJECTIVE: To describe a new management for cervical tumor. Preoperative planning using arteriography, successive occlusion of both vertebral arteries, and the cervical vertebrectomy are reported. SUMMARY OF BACKGROUND DATA: Thoracic or lumbar complete vertebrectomy for primary malignant tumor or metastasis is a well established surgical technique. The presence of the vertebral arteries appears to have prevented the previous use of complete vertebrectomy in the cervical spine.
METHODS: A 25-year-old male patient who had a giant cell tumor in C6 underwent hemi-vertebrectomy. Before this surgical procedure, the ipsilateral vertebral artery was embolized. The tumor recurred locally 18 months later. Using temporary balloon occlusion of the remaining vertebral artery, an abundant collateral circulation from the cervical arteries to the vertebrobasilar territory was shown. Triple total cervical vertebrectomy from C5-C7 was then performed with double stage surgery.
RESULTS: At 2-year follow-up, the patient is tumor-free.
CONCLUSIONS: Complete resection of malignant cervical vertebrae is possible if both vertebral arteries can be successively occluded, permitting complete removal of the transverse processes.

Entities:  

Mesh:

Year:  2005        PMID: 15897818     DOI: 10.1097/01.brs.0000162931.80082.04

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  8 in total

Review 1.  Multidisciplinary management of primary tumors of the vertebral column.

Authors:  Wesley Hsu; Thomas A Kosztowski; Hasan A Zaidi; Michael Dorsi; Ziya L Gokaslan; Jean-Paul Wolinsky
Journal:  Curr Treat Options Oncol       Date:  2009-06-23

2.  Seven-year survival after intralesional resection and adjuvant radiotherapy for a giant-cell tumour of the sixth cervical vertebra.

Authors:  Bernard Rerri; Temilolu Opadele
Journal:  Can J Surg       Date:  2009-08       Impact factor: 2.089

Review 3.  Denosumab in the treatment of giant cell tumor of the spine. Preliminary report, review of the literature and protocol proposal.

Authors:  Stefano Boriani; Riccardo Cecchinato; Fabrizio Cuzzocrea; Stefano Bandiera; Marco Gambarotti; Alessandro Gasbarrini
Journal:  Eur Spine J       Date:  2019-05-16       Impact factor: 3.134

4.  Multimodal Management of Combined Posterior and Anterior Surgical Approach and Postoperative Pharmacological Therapy for Giant Cell Tumor of the Cervical Spine Encasing the Vertebral Artery: A Technical Case Report.

Authors:  Yuichiro Tsuji; Yusuke Fukuo; Takuya Kanemitsu; Yoshihide Katayama; Ryokichi Yagi; Ryo Hiramatsu; Masahiro Kameda; Naosuke Nonoguchi; Motomasa Furuse; Shinji Kawabata; Ichiro Baba; Toshihiro Takami; Masahiko Wanibuchi
Journal:  Neurol Med Chir (Tokyo)       Date:  2022-08-27       Impact factor: 2.036

5.  Unilateral vertebral artery injury in a patient with displaced upper cervical spine fractures: the treatment for one case of vertebral artery embolism.

Authors:  Hong-Jun Zou; Jun Wu; Yong Hu; Dong Cheng; Jin-Bo Liu
Journal:  Eur Spine J       Date:  2017-11-08       Impact factor: 3.134

6.  Treatment options for recurrent giant cell tumors of bone.

Authors:  Maurice Balke; Helmut Ahrens; Arne Streitbuerger; Gabriele Koehler; Winfried Winkelmann; Georg Gosheger; Jendrik Hardes
Journal:  J Cancer Res Clin Oncol       Date:  2008-06-03       Impact factor: 4.553

7.  Giant cell tumor of cervicothoracic region treated by triple corpectomy from posterior only approach: A case report with review of literature.

Authors:  Rajat Mahajan; Harvinder Singh Chhabra; Vikas Tandon; Raghavendra Venkatesh
Journal:  J Craniovertebr Junction Spine       Date:  2015 Oct-Dec

8.  Recurrence Factors in Giant Cell Tumors of the Spine.

Authors:  Han-Qiang Ouyang; Liang Jiang; Xiao-Guang Liu; Feng Wei; Shao-Min Yang; Na Meng; Ping Jiang; Miao Yu; Feng-Liang Wu; Lei Dang; Hua Zhou; Hua Zhang; Zhong-Jun Liu
Journal:  Chin Med J (Engl)       Date:  2017-07-05       Impact factor: 2.628

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.